Antiplatelet treatment with ticlopidine in unstable angina. A controlled multicenter clinical trial. The Studio della Ticlopidina nell'Angina Instabile Group.
about
Adenosine-diphosphate (ADP) receptor antagonists for the prevention of cardiovascular disease in type 2 diabetes mellitusProtease-activated receptors 1 and 4 mediate activation of human platelets by thrombinUnstable angina and non-ST-segment elevation myocardial infarction: perspectives on combination therapyAntiplatelet therapy in populations at high risk of atherothrombosisCollaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' CollaborationHematologic dyscrasia associated with ticlopidine therapy: evidence for causality.Ticlopidine-induced aplastic anemia: two new case reports, review, and meta-analysis of 55 additional cases.Fatal neutropenia and thrombocytopenia associated with ticlopidine.Antiplatelet therapy--Part ITiclopidine hydrochloride use and threatened stroke.Predictors of risk in patients with unstable angina admitted to a district general hospital.Antiplatelet therapy in the prevention of ischemic vascular events: literature review and evidence-based guidelines for drug selection.North of England evidence based guideline development project: guideline on the use of aspirin as secondary prophylaxis for vascular disease in primary care. North of England Aspirin Guideline Development GroupRegular review: treatment possibilities for unstable angina.Newer antithrombotic strategies in the initial management of non-ST-segment elevation acute coronary syndromes.Current concepts in secondary prevention after acute myocardial infarction.The thienopyridines in coronary artery disease.Antithrombotic therapy in the cardiac catheterization laboratory: focus on antiplatelet agents.Antiplatelet medications and their indications in preventing and treating coronary thrombosis.Risk stratification in non-ST segment elevation acute coronary syndromes with special focus on recent guidelines.P2 receptors: new potential players in atherosclerosisAnti-thrombotic effects and bleeding risk of AJvW-2, a monoclonal antibody against human von Willebrand factor.Management of stable anginaOral platelet glycoprotein IIb/IIIa receptor inhibitors--Part I.Dynamics in thrombus formation.Aspirin for the prevention of vascular death in women.Antiplatelet drugs: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesRecent advances in the management of unstable angina and non-Q-wave myocardial infarctionPharmacotherapy of unstable angina.Antiplatelet and antithrombin strategies in acute coronary syndrome: state-of-the-art review.Ticlopidine-induced severe neutropeniaNew antiplatelet therapies for acute coronary syndromes.Platelet hyperactivity in type 2 diabetes: role of antiplatelet agents.Identification and management of polyvascular disease in patients with noncardioembolic ischaemic stroke.Platelet interactions as therapeutic targets for prevention of atherothrombosis.Thienopyridine therapy and risk for cardiovascular events in secondary prevention.Secondary prevention strategies for coronary heart disease.Balancing the benefits and risks of antiplatelet agents in patients with non-ST-segment elevated acute coronary syndromes and undergoing percutaneous coronary intervention.Antithrombotic therapy in patients with coronary artery disease and with type 2 diabetes mellitus.Contemporary treatment of unstable angina and non-ST-segment-elevation myocardial infarction (part 2).
P2860
Q24203035-E46D9A00-0BC9-4D6B-8DAB-B30573C183E0Q24563384-CB77E6B4-5021-4E91-90FE-D3D52140C401Q28192025-3399BDDD-9BFF-4699-823A-6232D23745FBQ28218702-5DCBE3FD-2732-406E-B6FB-065C7D9CB2EFQ29619529-D4EE2B4B-C45A-484F-BD8E-0CE7D0176E0CQ33335969-3D72BFB0-AC45-4329-AE06-F77AC242EFBCQ33344214-76B9245C-6EAF-44EA-8558-BAFB6BC1CB21Q33490373-8984F3A3-BB12-4487-9ACD-5AF324C15C4CQ33606832-5140D107-F0DC-4275-A0B9-9C6CFBE71A18Q33607265-21BF5532-AD45-4D23-A796-D32E202EF8DFQ33611971-674463EB-CB87-4D60-B673-7F83865019B1Q33732646-23E8B004-CB53-4C62-B2B1-20D144643051Q33789869-AF2D95A3-3F33-405A-BA2E-F66A9F0E7CE6Q33802938-E0ACDDEE-09D4-40C6-8429-A9080CD4B137Q33838920-55B785BC-55B2-4B14-95FC-FF197BD18A69Q33860933-4CCBA745-F206-4032-B829-0D60EE4261B5Q34027299-CECCE0B5-3BAE-4893-85E1-5A92386DF1B5Q34027525-28EE23B0-73E7-401B-B1CD-898AEF84F735Q34111901-E2466F62-5613-4CFF-AF2A-AF22CCC0B269Q34445660-9F397273-1C2B-4D43-B3F5-F2E079526F79Q34542194-A4701E6B-FE8F-483A-9772-A25EF7FC46E3Q35026617-9376AA84-5157-47AE-9F03-F32D40AA114DQ35168657-1BE365A4-E702-42E1-8C0E-B8B929D1126DQ35199720-673EF63A-8A09-4EB8-A6D1-CC99EFA7C7C7Q35224506-89ABCEB9-CB39-4A00-A8CF-75CAFCA459A5Q35657196-571DF8B7-16A5-44F3-84B9-61E1013B5A06Q35752619-E58C41F0-7B3E-4415-B7D9-D135B9738791Q35803300-51C42D8D-2235-456E-8855-89017C2B037BQ36119403-E93D3ED3-7758-45D1-ABBA-0FC13C95B933Q36302146-717781C9-EFDE-44AF-9644-F4C4FB311EA6Q36612741-701DFC00-1396-4A12-8978-50B41B795296Q36865090-23FAF8DB-16E0-47F6-BDE0-3EE7BFA3E323Q37184596-AA31EE68-01BC-4E4B-AD6A-FD83274D16FDQ37277220-BC7BCB0F-BABC-405A-B3EC-E1E8FD21A5E3Q37486621-060F9089-F65B-4A75-B54E-C38CBDA231C6Q37576116-991048C0-5D9D-42CD-A777-12F5CC4D8589Q37582800-03571D8F-559B-425D-B363-B9C5B0C35E1CQ37683552-11F61FD3-60DC-4736-9E7E-B54891B1965AQ37709191-8F4DC7ED-C2E5-4059-A394-36D726295464Q37765146-AB07EA50-CC26-4725-9727-63168EED5794
P2860
Antiplatelet treatment with ticlopidine in unstable angina. A controlled multicenter clinical trial. The Studio della Ticlopidina nell'Angina Instabile Group.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh
1990年學術文章
@zh-hant
name
Antiplatelet treatment with ti ...... a nell'Angina Instabile Group.
@en
Antiplatelet treatment with ti ...... a nell'Angina Instabile Group.
@nl
type
label
Antiplatelet treatment with ti ...... a nell'Angina Instabile Group.
@en
Antiplatelet treatment with ti ...... a nell'Angina Instabile Group.
@nl
prefLabel
Antiplatelet treatment with ti ...... a nell'Angina Instabile Group.
@en
Antiplatelet treatment with ti ...... a nell'Angina Instabile Group.
@nl
P2093
P356
P1433
P1476
Antiplatelet treatment with ti ...... a nell'Angina Instabile Group.
@en
P2093
Cimminiello C
Scrutinio D
P356
10.1161/01.CIR.82.1.17
P407
P577
1990-07-01T00:00:00Z